This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
After running into clinical hurdles with its “diamond in the rough” strategy, Lo...
Cystic fibrosis biotech Sionna Therapeutics will raise $191 million in its upsiz...
Novo Nordisk said Friday that its hemophilia A preventive Mim8 was effective in ...
→ Francisco Ballester is retiring as president, region international at Sandoz o...
The Mitsubishi Chemical Group is selling its centuries-old pharmaceutical busine...
The life science investment firm Bioluminescence Ventures will close its doors l...
A 66-year-old man whose kidneys were failing is now the fourth person who has re...
The Trump administration's reported plans to potentially lay off thousands of FD...
In the souring US-China relationship, there are winners and losers. DNA sequenci...
Sanofi, AstraZeneca and two leading trade groups want clarity around an appellat...
Sens. Dick Durbin (D-IL) and Roger Marshall (R-KS) are calling on the FDA to tak...
Welcome back to Endpoints Weekly! Our team tracked fourth-quarter earnings repor...
The FDA approved AbbVie and Pfizer's drug Emblaveo in combination with an older ...